Droplet digital PCR assay provides intrahepatic HBV cccDNA quantification tool for clinical application.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 02 2022
Historique:
received: 05 10 2021
accepted: 13 01 2022
entrez: 9 2 2022
pubmed: 10 2 2022
medline: 16 3 2022
Statut: epublish

Résumé

The persistence of covalently closed circular DNA (cccDNA) poses a major obstacle to curing chronic hepatitis B (CHB). Here, we used droplet digital PCR (ddPCR) for cccDNA quantitation. The cccDNA-specific ddPCR showed high accuracy with the dynamic range of cccDNA detection from 10

Identifiants

pubmed: 35136096
doi: 10.1038/s41598-022-05882-9
pii: 10.1038/s41598-022-05882-9
pmc: PMC8826402
doi:

Substances chimiques

DNA, Circular 0
DNA, Viral 0
Interferon-alpha 0
Recombinant Proteins 0
Polyethylene Glycols 3WJQ0SDW1A
peginterferon alfa-2a Q46947FE7K

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2133

Informations de copyright

© 2022. The Author(s).

Références

Hepatology. 2009 May;49(5 Suppl):S122-8
pubmed: 19399796
Liver Int. 2017 Jul;37(7):995-1001
pubmed: 27992681
J Clin Microbiol. 2007 Dec;45(12):3942-7
pubmed: 17942661
J Virol. 2001 Jan;75(1):311-22
pubmed: 11119601
Clin Gastroenterol Hepatol. 2015 Nov;13(12):2071-87.e16
pubmed: 26188135
J Biol Chem. 2005 Jun 10;280(23):21713-9
pubmed: 15814524
Aliment Pharmacol Ther. 2018 Jan;47(1):43-54
pubmed: 29035003
J Clin Microbiol. 1999 Sep;37(9):2899-903
pubmed: 10449472
Hepatology. 2009 May;49(5 Suppl):S166-73
pubmed: 19399793
Gastroenterology. 2009 Feb;136(2):652-62.e3
pubmed: 19041311
Gene. 1995 Sep 22;163(1):41-6
pubmed: 7557476
Gut. 2018 Mar;67(3):542-552
pubmed: 28428345
Hepatol Res. 2019 Mar;49(3):271-283
pubmed: 30358027
Hepatology. 2004 Sep;40(3):727-37
pubmed: 15349913
Science. 2014 Mar 14;343(6176):1221-8
pubmed: 24557838
Clin Gastroenterol Hepatol. 2007 Dec;5(12):1462-8
pubmed: 18054753
Biotechnol Lett. 2015 Oct;37(10):2063-73
pubmed: 26187315
J Hepatol. 2017 Feb;66(2):275-281
pubmed: 27639844
Sci Rep. 2017 Dec;7(1):173
pubmed: 28282964
J Hepatol. 2015 Sep;63(3):546-53
pubmed: 25817219
J Hepatol. 2018 Aug;69(2):301-307
pubmed: 29621551
J Mol Diagn. 2018 May;20(3):334-343
pubmed: 29656833
Nat Methods. 2013 Oct;10(10):1003-5
pubmed: 23995387
J Viral Hepat. 2004 Mar;11(2):124-9
pubmed: 14996346
Hepatology. 2006 Oct;44(4):915-24
pubmed: 17006908
Sci Rep. 2017 Oct 27;7(1):14631
pubmed: 29079791
J Hepatol. 2021 Feb;74(2):283-292
pubmed: 32931877
Hepatology. 2009 Apr;49(4):1141-50
pubmed: 19338056
J Clin Microbiol. 2017 Oct;55(10):2972-2982
pubmed: 28747369
Antiviral Res. 2006 Nov;72(2):116-24
pubmed: 16780964
Sci Rep. 2020 Dec 3;10(1):21097
pubmed: 33273565
Virology. 2013 Nov;446(1-2):357-64
pubmed: 24074600
Hepatology. 2004 Sep;40(3):747-55
pubmed: 15349915
Anal Chem. 2011 Nov 15;83(22):8604-10
pubmed: 22035192
Sci Rep. 2018 Feb 26;8(1):3626
pubmed: 29483619

Auteurs

Sanae Hayashi (S)

Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Masanori Isogawa (M)

Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Keigo Kawashima (K)

Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Kyoko Ito (K)

Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Natthaya Chuaypen (N)

Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Yuji Morine (Y)

Department of Surgery, Tokushima University, Tokushima, Japan.

Mitsuo Shimada (M)

Department of Surgery, Tokushima University, Tokushima, Japan.

Nobuyo Higashi-Kuwata (N)

Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.

Takehisa Watanabe (T)

Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Pisit Tangkijvanich (P)

Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Hiroaki Mitsuya (H)

Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Department of Clinical Sciences, Kumamoto University Hospital, Kumamoto, Japan.

Yasuhito Tanaka (Y)

Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. ytanaka@kumamoto-u.ac.jp.
Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan. ytanaka@kumamoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH